Your search returned 2 results.

Results
	1.	A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis. [electronic resource] by Schorpion, Annemarie Shenin, Max Neubauer, Robin Derk, Chris T Publication details: BMC rheumatology 2018 In: BMC rheumatology vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients. [electronic resource] by Trofe-Clark, Jennifer Brennan, Daniel C West-Thielke, Patricia Milone, Michael C Lim, Mary Ann Neubauer, Robin Nigro, Vincenza Bloom, Roy D Producer: 20190814 In: American journal of kidney diseases : the official journal of the National Kidney Foundation vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search